Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Revenue | $ 8,011,610 | $ 5,369,147 | $ 14,473,364 | $ 9,742,051 |
| Direct product costs | 2,330,512 | 1,884,804 | 4,275,716 | 3,587,584 |
| Gross Profit | 5,681,098 | 3,484,343 | 10,197,648 | 6,154,467 |
| Operating Expenses: | ||||
| Research and development | 2,073,444 | 2,169,789 | 4,057,234 | 4,662,716 |
| Sales and marketing | 1,511,340 | 1,483,897 | 3,122,020 | 3,369,362 |
| General and administrative | 1,132,744 | 1,185,731 | 2,101,104 | 2,639,291 |
| Total Operating Expenses | 4,717,528 | 4,839,417 | 9,280,358 | 10,671,369 |
| Operating Income (Loss) | 963,570 | (1,355,074) | 917,290 | (4,516,902) |
| Other Income (Expenses): | ||||
| Interest income | 21,250 | 49,156 | 43,055 | 114,785 |
| Interest expense | (218,592) | (242,289) | (422,643) | (453,059) |
| Change in fair value of warrant liabilities | (2,998,281) | 1,079,717 | (2,069,131) | 843,821 |
| Other income (expense) | (808) | (2,252) | 420,173 | (2,252) |
| Total Other Income (Expenses), net | (3,196,431) | 884,332 | (2,028,546) | 503,295 |
| Net Loss | $ (2,232,861) | $ (470,742) | $ (1,111,256) | $ (4,013,607) |
| Net Loss Per Share - Basic and Diluted (in dollars per share) | $ (0.21) | $ (0.05) | $ (0.1) | $ (0.39) |
| Weighted Average Common Shares Outstanding - Basic and Diluted (in shares) | 10,649,162 | 10,381,182 | 10,641,629 | 10,342,255 |
| Product [Member] | ||||
| Revenue | $ 8,011,610 | $ 5,282,449 | $ 14,464,475 | $ 9,655,353 |
| Royalty and Non-recurring Engineering [Member] | ||||
| Revenue | $ 0 | $ 86,698 | $ 8,889 | $ 86,698 |
| X | ||||||||||
- Definition Amount of interest income classified as nonoperating. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|